Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - GLAXOSMITHKLINE PLC
Last Updated 
2-Apr-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

GLAXOSMITHKLINE PLC: Declared Holdings
Company/RelationshipReportedShares  Ownership
Applied Genetic Technologies Co
Beneficial Owner (10% or more)
NasdaqGM:AGTC
(historical quotes, profile, other insiders)
1-Apr-141,989,598  Indirect
Concert Pharmaceuticals, Inc.
Other
NasdaqGM:CNCE
(historical quotes, profile, other insiders)
19-Feb-141,356,533  Indirect
Amicus Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:FOLD
(historical quotes, profile, other insiders)
20-Nov-1311,315,825  Indirect
Genocea Biosciences, Inc.
Other
NasdaqGM:GNCA
(historical quotes, profile, other insiders)
10-Feb-141,671,667  Indirect
OncoMed Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGS:OMED
(historical quotes, profile, other insiders)
23-Jul-132,607,546  Indirect
NuPathe Inc.
Other
NasdaqGM:PATH
(historical quotes, other insiders)
21-Feb-140  Indirect
Response Genetics, Inc.
Beneficial Owner (10% or more)
NasdaqCM:RGDX
(historical quotes, profile, other insiders)
13-Sep-125,000,000  Indirect
Theravance, Inc.
Beneficial Owner (10% or more)
NasdaqGS:THRX
(historical quotes, profile, other insiders)
11-Feb-1430,258,302  Indirect

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
1-Apr-14 *103,762AGTC Purchase at $12 per share.
(Cost of $1,245,144)
1-Apr-14 *1,885,836AGTC Acquisition (Non Open Market)
21-Feb-14 *4,168,017PATH Disposition (Non Open Market)
19-Feb-14 *1,321,533CNCE Acquisition (Non Open Market)
19-Feb-14 *35,000CNCE Purchase at $14 per share.
(Cost of $490,000)
11-Feb-14 *342,229THRX Purchase at $37.55 per share.
(Cost of $12,850,698)
10-Feb-14 *1,527,894GNCA Acquisition (Non Open Market)
10-Feb-14 *143,773GNCA Purchase at $12 per share.
(Cost of $1,725,276)
6-Feb-14 *1,500,000PATH Acquisition (Non Open Market) at $2 per share.
(Value of $3,000,000)
20-Nov-13 *1,500,000FOLD Purchase at $2 per share.
(Cost of $3,000,000)
29-Oct-13 *130,473THRX Purchase at $37.66 per share.
(Cost of $4,913,613)
30-Jul-13 *3,064,407THRX Purchase at $36.50 per share.
(Cost of $111,850,855)
23-Jul-13 *2,607,546OMED Acquisition (Non Open Market)
30-Apr-13 *193,563THRX Purchase at $34.61 per share.
(Cost of $6,699,215)
15-Feb-13 *116,527THRX Purchase at $22.03 per share.
(Cost of $2,567,089)
2-Nov-12 *280,348THRX Purchase at $22.35 per share.
(Cost of $6,265,777)
13-Sep-12 *5,000,000RGDX Statement of Ownership
3-Aug-12 *316,334THRX Purchase at $28.21 per share.
(Cost of $8,923,782)
17-Jul-12 *2,949,581FOLD Purchase at $6.30 per share.
(Cost of $18,582,360)
16-May-12 *10,000,000THRX Purchase at $21.29 per share.
(Cost of $212,900,000)
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?